Skip to main content
. 2012 Sep 29;16(4):338–340. doi: 10.5114/wo.2012.30064

Table 2.

Threshold value of EBV-DNA copies as an indicator for preemptive treatment with rituximab

Number of EBV-DNA copies/ml Number of centers
1 × 103 19 (31.7%)
5 × 103 1 (1.7%)
1 × 104 20 (33.3%)
4–5 × 104 6 (10%)
1 × 105 9 (15%)
other (risk factors, increasing value) 5 (8.3%)

EBV-DNA – Epstein-Barr virus deoxyribonucleic acid